Next Article in Journal
Hemoglobin A1c Levels Modify Associations between Dietary Acid Load and Breast Cancer Recurrence
Previous Article in Journal
Evidence for Dietary Agmatine Sulfate Effectiveness in Neuropathies Associated with Painful Small Fiber Neuropathy. A Pilot Open-Label Consecutive Case Series Study
Open AccessArticle

Zinc Burden Evokes Copper Deficiency in the Hypoalbuminemic Hemodialysis Patients

1
Nephrology Department, Rakuwakai Nijo Ekimae Clinic, 3Higashitoganoo-cho, Nishinokyo, Nakagyo Ward, Kyoto City 604-8414, Japan
2
Nephrology Department, Rakuwakai Toji Minami Hospital, 1Nishikujo, Nanden-cho, Minami Ward, Kyoto 601-8441, Japan
3
Graduate School of Home Economics, Kyoto Women’s University, 35Imakumano, Kitahiyoshi-cho, Higashiyama Ward, Kyoto 605-0926, Japan
4
Department of Nephrology, Rakuwakai Otowa Hospital, 2 Otowa Chinji-cho, Yamashina, Kyoto 607-8062, Japan
*
Author to whom correspondence should be addressed.
Nutrients 2020, 12(2), 577; https://doi.org/10.3390/nu12020577
Received: 27 January 2020 / Revised: 21 February 2020 / Accepted: 21 February 2020 / Published: 23 February 2020
Background: Recent research has focused on the roles of trace minerals such as zinc and copper. In 2017, oral zinc acetate was approved to treat zinc deficiency, and the next year, the Japanese Society for Clinical Nutrition developed the guidelines for diagnosis and treatment for zinc deficiency. Accordingly, hemodialysis patients began receiving zinc acetate when zinc deficiency was diagnosed. However, studies regarding the values of zinc and copper in hemodialysis patients are extremely poor, thus it remains unclear if the guidelines for healthy subjects can be applied to hemodialysis patients. Methods: We conducted a descriptive study, in which 132 patients were subjected to simply examine serum zinc concentration and its association with copper levels in hemodialysis patients (N = 65) versus healthy individuals attending a routine check-up (control group; N = 67) in our hospital. Analyses were performed with BellCurve for Excel (Social Survey Research Information Co., Ltd. Tokyo, Japan). Results: The distribution of zinc level in the hemodialysis group was distinct from that in the control group (P < 0.001). The zinc level was correlated with serum albumin concentration. Zinc concentration was also negatively correlated with serum copper level in both groups. In the hemodialysis group, the upper limit of zinc to avoid copper deficiency was 109.7 μg/dL, and the safety upper limit was 78.3 μg/dL. Conclusions: Hemodialysis patients exhibited a lower level of zinc concentration compared to normal healthy subjects. Since albumin binds to zinc as a carrier, low zinc levels could be attributed to lower level of serum albumin. Importantly, zinc and copper levels were inversely correlated, thus administration of oral zinc acetate could increase a risk for copper deficiency. It might be better to check both zinc and copper values monthly after prescribing zinc acetate. View Full-Text
Keywords: hemodialysis; zinc; copper; zinc-induced copper deficiency (ZICD); copper deficiency-induced myeloneuropathy (CDM) hemodialysis; zinc; copper; zinc-induced copper deficiency (ZICD); copper deficiency-induced myeloneuropathy (CDM)
Show Figures

Figure 1

MDPI and ACS Style

Nishime, K.; Kondo, M.; Saito, K.; Miyawaki, H.; Nakagawa, T. Zinc Burden Evokes Copper Deficiency in the Hypoalbuminemic Hemodialysis Patients. Nutrients 2020, 12, 577.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop